Document is current
Any future updates will be listed below
-
Authors
Baer, Constance https://orcid.org/0000-0002-8571-1551
Huber, Sandra
Hutter, Stephan https://orcid.org/0000-0003-2432-8898
Meggendorfer, Manja
Nadarajah, Niroshan
Walter, Wencke https://orcid.org/0000-0002-5083-9838
Platzbecker, Uwe https://orcid.org/0000-0003-1863-3239
Götze, Katharina S.
Kern, Wolfgang https://orcid.org/0000-0002-6452-2874
Haferlach, Torsten
Hoermann, Gregor
Haferlach, Claudia https://orcid.org/0000-0002-6333-5049
- License Information
-
More Information
Article History
Received: 2 December 2022
Revised: 17 January 2023
Accepted: 19 January 2023
First Online: 1 February 2023
Competing interests
: CH, WK and TH declare part ownership of MLL Munich Leukemia Laboratory. CB, SH, StH, MM, NN, WW and GH are employed by MLL Munich Leukemia Laboratory. UP has received honoraria and research support by BMS, Janssen, Novartis. KSG has received honoraria from BMS, Abbvie, Pfizer and JAZZ pharmaceuticals.
